Late Breakers
Top 5 Industry Updates
Tralokinumab Shows Consistent Efficacy in Atopic Dermatitis Regardless of Coexisting Atopic Conditions
No Postoperative Pancreatic Fistula Outcomes Difference Between Blumgart and Pancreatogastrostomy Anastomosis
A new study reports that postoperative pancreatic fistula outcomes after pancreatogastrostomy do not differ between patients undergoing Blumgart anastomosis and pancreatogastrostomy anastomosis; however, the latter leads to better postoperative quality of life
Industry Information
DUPIXENT® (dupilumab) APPROVED FOR AN 8th INDICATION
Learn about the new approval for DUPIXENT
Novel Risk Score Predicts Post-transplant Recurrence in Perihilar Cholangiocarcinoma
A new study documents the validation and application of a risk score for predicting post-transplant recurrence in perihilar cholangiocarcinoma.
Industry Information
New Data Show 40-Gene Expression Profile (DecisionDx®-SCC) Identifies Cutaneous Squamous Cell Carcinoma Patients Most Likely to Benefit from Adjuvant Radiation Therapy
Study results demonstrate that DecisionDx-SCC can identify high-risk cutaneous squamous cell carcinoma patients who are most likely to benefit from adjuvant radiation therapy.
Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia
A randomized trial finds that botulinum toxin A, whether administered subcutaneously or via combined subcutaneous and intramuscular injection, shows no meaningful improvement in hair growth outcomes in men with androgenetic alopecia.